Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: A preliminary study

American Journal of Physical Medicine and Rehabilitation

Volumn 85, Issue 1, 2006, Pages 75-81

  Bayram, Suheda ^a   Sivrioglu, Koncuy ^a   Karli, Necdet ^a   Ozcan, Orhan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Botulinum Toxin; Drop Foot; Electrical Stimulation; Spasticity

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADULT; ANKLE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROSTIMULATION THERAPY; FEMALE; FOOT DROP; GASTROCNEMIUS MUSCLE; HUMAN; LOW DRUG DOSE; MALE; MUSCLE WEAKNESS; MYALGIA; NEUROMUSCULAR DISEASE; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; RATING SCALE; SCORING SYSTEM; SOLEUS MUSCLE; SPASTICITY; STATISTICAL SIGNIFICANCE; STROKE; TIBIALIS POSTERIOR MUSCLE; TREATMENT OUTCOME; WALKING;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; BRACES; CEREBROVASCULAR ACCIDENT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 29344435798     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.phm.0000193505.85874.61     Document Type: Article

References (32)

1. Ko CK, Ward AB: Management of spasticity. Br J Hosp Med 1997;58:400-5
2. Montane E, Vallano A, Laporte JR: Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review. Neurology 2004;63:1357-63
3. Gracies JM: Physical modalities other than stretch in spastic hypertonia. Phys Med Rehabil Clin N Am 2001;12:769-92
4. Lazorthes Y, Sol JC, Sallerin B, et al: The surgical management of spasticity. Eur J Neurol 2002;9(suppl 1):35-41
5. Jankovic J, Brin MF: Botulinum toxin: Historical perspective and potential new indications. Muscle Nerve 1997;20(suppl 6):S129-45
6. Bhakta BB, Cozens JA, Bamford JM, et al: Use of botulinum toxin in stroke patients with severe upper limb spasticity. J Neurol Neurosurg Psychiatry 1996;61:30-5
7. Simpson DM, Alexander DN, O'Brien CF, et al: Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial. Neurology 1996;46:1306-10
8. Hesse S, Reiter F, Konrad M, et al: Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: A randomized, double-blind, placebo-controlled trial. Clin Rehabil 1998;12:381-8
9. Reiter F, Danni M, Ceravolo MG, et al: Disability changes after treatment of upper limb spasticity with botulinum toxin. J Neurol Rehabil 1996;10:47-52
10. Sampaio C, Ferreira JJ, Pinto AA, et al: Botulinum toxin type A for the treatment of arm and hand spasticity in stroke patients. Clin Rehabil 1997;11:3-7
11. Yablon SA, Agana BT, Ivanhoe CB, et al: Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: An open-labeled trial. Neurology 1996;47:939-44
12. Bakheit AMO, Sawyer J: The effects of botulinum toxin treatment on associated reactions of the upper limb on hemiplegic gait: A pilot study. Disabil Rehabil 2002;24:519-22
13. Francis HP, Wade DT, Turner-Stokes L, et al: Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. J Neurol Neurosurg Psychiatry 2004;75:1547-51
14. Bakheit AMO, Pittock S, Moore AP, et al: A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001;8:559-65
15. Dengler R, Neyer U, Wohlfarth K, et al: Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239:375-8
16. Hesse S, Jahnke MT, Luecke D, et al: Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 1995;201:37-40
17. Burbaud P, Wiart L, Dubos JL, et al: A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. J Neurol Neurosurg Psychiatry 1996;61:265-9
18. Hesse S, Lucke D, Malezic M, et al: Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994;57:1321-4
19. Pierson SH, Katz DI, Tarsy D: Botulinum toxin A in the treatment of spasticity: Functional implications and patient selection. Arch Phys Med Rehabil 1996;77:717-21
20. Kirazli Y, On AY, Kismali B, et al: Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: A randomized, double-blind trial. Am J Phys Med Rehabil 1998;77:510-5
21. Reiter F, Danni M, Lagalla G, et al: Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil 1998;79:532-5
22. Simpson LL: Kinetic studies on interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 1980;212:16-21
23. 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor- mediated endocytosis. J Cell Biol 1986;103:535-44
24. Johnson CA, Burridge JH, Strike PW, et al: The effect of combined use of botulinum toxin type A and functional electrical stimulation in the treatment of spastic drop foot after stroke: A preliminary investigation. Arch Phys Med Rehabil 2004;85:902-9
25. Leis AA, Trapani VC: Atlas of Electromyography. New York, Oxford University Press, 2000
26. Chae J, Bethoux F, Bohinc T, et al: Neuromuscular stimulation for upper extremity motor and functional recovery in acute hemiplegia. Stroke 1998;29:975-9
27. Pandyan AD, Granat MH, Stott DJ: Effects of electrical stimulation on flexion contractures in the hemiplegic wrist. Clin Rehabil 1997;11:123-30
28. Han JS, Chen XH, Yuan Y, et al: Transcutaneous electrical nerve stimulation for treatment of spinal spasticity. Chin Med J (Engl) 1994;107:6-11
29. Seib TP, Price R, Reye MR, et al: The quantitative measurement of spasticity: Effect of cutaneous electrical stimulation. Arch Phys Med Rehabil 1994;75:746-50
30. Dunne JW, Heye N, Dunne SL: Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg Psychiatry 1995;58:232-5
31. Hesse S, Krajnik J, Luecke D, et al: Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. Stroke 1996;27:455-60
32. Childers MK, Brashear A, Jozefczyk P, et al: Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke. Arch Phys Med Rehabil 2004;85:1063-9